Home › Funds › Clark Capital Management Group, Inc. › GMED
Clark Capital Management Group, Inc. position in GMED
GLOBUS MED INC · Health Care
Clark Capital Management Group, Inc. reported holding 1,177,836 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$88.2M, representing 0.53% of its reported portfolio and ranking #42 among its reported holdings. Clark Capital Management Group, Inc. has disclosed GMED holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Clark Capital Management Group, Inc.'s GMED position evolved
Clark Capital Management Group, Inc. first disclosed a stake in GMED in Q1 2026 at 100,687 shares (US$8.7M). The position peaked in Q3 2026 at 1,177,836 shares, worth US$88.2M. Across 3 filings, Clark Capital Management Group, Inc. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,177,836 shares valued at US$88.2M — an increase of 490,937 shares quarter over quarter.. Notable position changes include a 582% increase in Q2 2026 (shares fell 5% over the following quarter), a 71% increase in Q3 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 100.69K | $8.68M | New |
| Q2 2026 | 686.90K | $54.27M | Add |
| Q3 2026 | 1.18M | $88.22M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 35 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$239.4M), Boston Trust Walden Corp (US$123.1M), GW&K Investment Management, LLC (US$110.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 3.20M sh · $239.44M · Q3 2026
- Boston Trust Walden Corp 1.64M sh · $123.07M · Q3 2026
- GW&K Investment Management, LLC 1.47M sh · $110.29M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.25M sh · $93.58M · Q3 2026
More on Clark Capital Management Group, Inc.
FAQ
How long has Clark Capital Management Group, Inc. held GMED?
Clark Capital Management Group, Inc. has disclosed GMED holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Clark Capital Management Group, Inc.'s current position in GMED?
As of Q3 2026, Clark Capital Management Group, Inc. holds 1.18M shares of GMED (GLOBUS MED INC), valued at $88.22M, representing 0.53% of its reported portfolio and ranking #42.
Has Clark Capital Management Group, Inc. been buying or selling GMED?
In the latest 13F filing (Q3 2026), Clark Capital Management Group, Inc. increased its position in GMED. The position peaked in Q3 2026 at 1.18M shares.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Boston Trust Walden Corp, GW&K Investment Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.